Arthur S Kirsch

Director

Arthur S Kirsch (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Evommune, Inc. (EVMN). Across 1 priced purchase filing, the average 21-session return was +5.0% from execution and -1.1% from disclosure (delay-adjusted; derived). The largest single filing was $1.7M of LQDA (30,000 sh across 3 lots, as filed), executed Jun 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+5.0%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-1.1%

same 1 filings, from disclosure

Filings, ttm

1 buys · 1 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.9M

shares × price, as filed

Last traded

Jul 7

Filed Jul 8

Median ADV $143.6M across their filed names

Open performance→

Volume by month

Buys $133K Sells $1.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

EVMN

Evommune, Inc. EVMN · 1 buy · 0 sells 1 filing LQDA Liquidia Corporation LQDA · 0 buys · 1 sell 1 filing

Recent filings

EVMNPURCHASE Evommune, Inc. View filing → $133K
10,000 sh × $13.30
Exec Jul 7
Filed Jul 8 · 8:00 PM ET LQDASALE Liquidia Corporation View filing → $1.7M
30,000 sh across 3 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET